2022 annual financial data
NervGen Pharma 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -22,822,534 CAD and net income was -20,540,037 CAD.
Operating cash flow was -17,627,757 CAD.
Get free NervGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -22,822,534 CAD
- Net income
- -20,540,037 CAD
- Operating cash flow
- -17,627,757 CAD